TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharma-Hus AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
27,475
|
30,599
|
27,052 |
| Financial expenses |
0
|
1
|
2 |
| Earnings before taxes |
1,485
|
977
|
263 |
| EBITDA |
1,571
|
1,114
|
387 |
| Total assets |
6,810
|
0
|
9,303 |
| Current assets |
6,650
|
0
|
8,718 |
| Current liabilities |
3,776
|
0
|
7,151 |
| Equity capital |
2,661
|
0
|
1,784 |
| - share capital |
103
|
0
|
95 |
| Employees (average) |
4
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency | 39.1% | 19.2% | |
| Turnover per employee |
6,869
|
6,120
|
5,410 |
| Profit as a percentage of turnover |
5.4%
|
3.2%
|
1.0% |
| Return on assets (ROA) | 21.8% | 2.8% | |
| Current ratio | 176.1% | 121.9% | |
| Return on equity (ROE) | 55.8% | 14.7% | |
| Change turnover |
-3,676
|
1,627
|
1,131 |
| Change turnover % |
-12%
|
6%
|
4% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-20%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.